Format

Send to

Choose Destination
Hematol Oncol Clin North Am. 2004 Oct;18(5):1007-21, viii.

Epidermal growth factor receptor in tumor angiogenesis.

Author information

1
The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 444, Houston, TX 77030-4009, USA. lellis@mail.mdanderson.org

Abstract

This article focuses on the preclinical evidence for activation of the epidermal growth factor receptor (EGFR) in promoting angiogenesis and the efficacy of anti-EGFR agents in inhibiting angiogenesis and tumor growth.

PMID:
15474332
DOI:
10.1016/j.hoc.2004.06.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center